Specify a stock or a cryptocurrency in the search bar to get a summary
Roche Holding AG
RORoche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland. Address: Grenzacherstrasse 124, Basel, Switzerland, 4058
Analytics
WallStreet Target Price
212.41 CHFP/E ratio
22.2642Dividend Yield
3.25 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures RO
Dividend Analytics RO
Dividend growth over 5 years
14 %Continuous growth
28 yearsPayout Ratio 5 years average
57 %Dividend History RO
Stock Valuation RO
Financials RO
Results | 2019 | Dynamics |